Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Point-of-Care (POC) Coagulation Testing Market Size Changed, over the years?
The size of the point-of-care (POC) coagulation testing market has seen significant growth in recent years. The market is projected to expand from $1.18 billion in 2024 to $1.25 billion in 2025, with a compound annual growth rate (CAGR) of 5.8%. The historic growth can be credited to the increase in patient demand, the popularity of point-of-care testing, the dependability of coagulation status on pt test, automation and amalgamation with electronic health records (EHRs), and a growing prevalence of cardiovascular diseases and blood conditions.
How Much Will the Point-of-Care (POC) Coagulation Testing Market Be Worth in 2029?
Anticipated to experience consistent expansion in the coming years, the point-of-care (POC) coagulation testing market is forecasted to hit $1.48 billion by 2029, with a compound annual growth rate (CAGR) of 4.2%. Factors contributing to this growth during the forecast period include an increase in healthcare applications, escalated demand in homecare settings, a rise in chronic blood disorder cases, patient preference for quick and precise testing, and an increase in point-of-care testing. Notable trends in the forecast period encapsulate technological progress, increased demand in developed nations, broadening healthcare applications, the impact of COVID-19, and the integration of multiplexing POC diagnostics.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13913&type=smp
Which is the Largest Company in the Point-of-Care (POC) Coagulation Testing Market?
Major companies operating in the point-of-care (POC) coagulation testing market report are AT&T Corporation, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, Medtronic Plc, Koninklijke Philips N.V., Sysmex Corporation, IDEXX Laboratories Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Teleflex Incorporated, Werfen SA, Nihon Kohden Corporation, Horiba Ltd., Hycel, Nova Biomedical Corporation, Haemonetics Corporation, Maccura Biotechnology Co. Ltd., Helena Laboratories Corporation, Abaxis Inc., ARKRAY Inc., Radiometer Medical ApS, HemoSonics LLC, iLine Microsystems SL, Corgenix Medical Corporation, Quotient Limited, Micropoint Bioscience Inc., Beijing Succeeder Technology Inc., EKF Diagnostics Holdings plc
What Are the Main Market Drivers in the Point-of-Care (POC) Coagulation Testing Industry?
An increase in cardiovascular illnesses is predicted to fuel the growth of the point-of-care (POC) coagulation testing market in the future. These cardiovascular diseases (CVDs) encompass various heart and blood vessel disorders, including diseases like coronary heart disease, cerebrovascular disease, and peripheral arterial disease. POC coagulation testing proves beneficial in treating these diseases, as it offers immediate data on coagulation conditions, helping to make decisions about coagulation interventions promptly, and lessening the likelihood of bleeding issues post heart surgery. For instance, the World Heart Federation, a Swiss non-governmental organization, issued a report in October 2022, forecasting a rise in fatalities due to cardiovascular diseases. The report suggested the number of deaths caused by CVDs is likely to increase from nearly 18.9 million in 2020 to more than 22.2 million by 2030, and eventually hit 32.3 million by 2050. Consequently, this surge in cardiovascular illnesses will contribute significantly to the growth of the point-of-care (POC) coagulation testing market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=13913&type=smp
How Is the Point-of-Care (POC) Coagulation Testing Market Segments Structured?
The point-of-care (POC) coagulation testing market covered in this report is segmented –
1) By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology
2) By Distribution Channel: Direct Tenders, Retail
3) By End-User: Hospitals, Clinics, Home care
Subsegments:
1) By Optical Technology: Reflectance Photometry, Fluorescence Detection, Colorimetric Detection
2) By Mechanical Technology: Mechanical Oscillation, Ultrasonic Detection
3) By Electrochemical Technology: Amperometric Detection, Potentiometric Detection, Conductometric Detection
What Strategic Trends Are Transforming the Point-of-Care (POC) Coagulation Testing Market?
Leading companies in the point-of-care (POC) coagulation testing market are leveraging strategic partnerships for gaining a competitive advantage in the industry. A strategic collaboration represents a formalized agreement between two or more entities working together towards predetermined, mutually beneficial objectives. To illustrate, in January 2023, Jana Care, a company from the United States that is developing biomarker assays for its exclusive digital health platform, entered into a collaboration with Roche Diagnostics, a Switzerland-based company that pioneers diagnostic testing, equipment, and digital solutions with significant healthcare impact. The joint venture aims to create and distribute a point-of-care blood testing platform targeted for the screening of chronic kidney disease and heart failure. This ground-breaking platform will allow patients to execute blood tests from their homes, with the test results being evaluated remotely by medical professionals.
Access The Full Report Here:
Which Global Regions Offer the Highest Growth in the Point-of-Care (POC) Coagulation Testing Market?
North America was the largest region in the point-of-care (POC) coagulation testing market in 2024. The regions covered in the point-of-care (POC) coagulation testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13913
This Report Delivers Insight On:
1. How big is the point-of-care (poc) coagulation testing market, and how is it changing globally?
2. Who are the major companies in the point-of-care (poc) coagulation testing market, and how are they performing?
3. What are the key opportunities and risks in the point-of-care (poc) coagulation testing market right now?
4. Which products or customer segments are growing the most in the point-of-care (poc) coagulation testing market?
5. What factors are helping or slowing down the growth of the point-of-care (poc) coagulation testing market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
